EFFICACY AND SAFETY RESULTS FROM PRINCIPAL: A REAL …

IN THE VOTRIENT PHASE 3 PIVOTAL TRIAL: • 11.1 months median PFS in first-line patients vs 2.8 months with placebo (HR=0.40 [95% CI, 0.27-0.60], ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download